Anebulo Pharmaceuticals Financial Overview
Anebulo Pharmaceuticals's market cap is currently $91.62M. The company's EPS TTM is $-0.05; its P/E ratio is -10.03; Anebulo Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
